An international research team, led by scientists from Mater Research—The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which ...
Apr 16, 2020
0
332
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their ...
Sep 28, 2019
0
5
Affecting as many as 30% of cancer survivors, chronic insomnia can be effectively treated with intensive cognitive-behavioral techniques, but such methods are time-consuming, costly, and limited by the availability of trained ...
Sep 24, 2019
0
2
A strain of the common cold virus has been found to potentially target, infect and destroy cancer cells in patients with bladder cancer, a new study in the medical journal Clinical Cancer Research reports. No trace of the ...
Jul 5, 2019
3
10
New research recently published in the Journal of Pediatric Surgery found that post-operative success rates of pediatric thyroid patients, particularly children who require a thyroidectomy, correlate with the institution's ...
Apr 4, 2019
0
1
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial ...
Mar 6, 2019
0
0
Through a global gene expression analysis (transcriptomic), the researchers were able to find and confirm a genetic signature common to genodermatoses in patients' cells. The profile targets cellular activation and alteration ...
Mar 5, 2019
0
1
A small number of women require re-operation after breast-conserving surgery (BCS) for breast cancer, if the surgical margins are not free from cancer.
Dec 19, 2018
0
0
New research undertaken at Monash University has shed new light on how some cancers are able to escape our immune system.
Dec 6, 2018
0
21
About half of all melanomas have mutations in the BRAF gene that accelerate tumor cell growth and spread. While most patients benefit from targeted anti-BRAF therapy, resistance to treatment and tumor progression is almost ...
Apr 12, 2018
0
2
